Palomero, J., Panisello, C., Lozano-Rabella, M., Tirtakasuma, R., Díaz-Gómez, J., Grases, D., . . . Gros Vidal, A. (2022). Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.
Citación estilo ChicagoPalomero, Jara, et al. Biomarkers of Tumor-reactive CD4+ and CD8+ TILs Associate With Improved Prognosis in Endometrial Cancer. 2022.
Cita MLAPalomero, Jara, et al. Biomarkers of Tumor-reactive CD4+ and CD8+ TILs Associate With Improved Prognosis in Endometrial Cancer. 2022.
Precaución: Estas citas no son 100% exactas.